Attached files

file filename
EX-99.1 - EX-99.1 - Endo International plcd52658dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 20, 2015 (November 20, 2015)

 

 

ENDO INTERNATIONAL PLC

(Exact Name of Registrant as Specified in Charter)

 

 

 

Ireland   001-36326   68-0683755

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland

(Address of principal executive offices)

Registrant’s telephone number, including area code 011-353-1-268-2000

Not Applicable

Former name or former address, if changed since last report

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01. Other Events.

Conditional Redemption of 2020 Endo Finance Notes and 2020 EHSI Notes

On November 20, 2015, Endo International plc (the “Company”) issued a press release announcing that (1) Endo Finance LLC and Endo Finco Inc. (collectively, the “Endo Finance Issuers”), wholly-owned subsidiaries of the Company, will redeem, subject to the satisfaction of the condition described below, all $392,963,000 aggregate principal amount outstanding of their 7.00% Senior Notes due 2020 (the “2020 Endo Finance Notes”) on December 21, 2015 and (2) Endo Health Solutions Inc. (“EHSI”), a wholly-owned subsidiary of the Company, will redeem, subject to the satisfaction of the condition described below, all $7,037,000 aggregate principal amount outstanding of its 7.00% Senior Notes due 2020 (the “2020 EHSI Notes”) on December 21, 2015. Each of the redemptions is conditional and subject to the delivery of moneys sufficient to pay the applicable redemption price to Wells Fargo Bank, National Association, the trustee, on the redemption date. On November 20, 2015, the conditional notices of redemption with respect to the 2020 Endo Finance Notes and the 2020 EHSI Notes, respectively, were delivered to record holders of such notes. A copy of the Company’s press release announcing the conditional redemption of the 2020 Endo Finance Notes and the 2020 EHSI Notes is filed herewith as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

99.1    Press Release of Endo International plc, dated November 20, 2015, related to the conditional redemption of the 2020 Endo Finance Notes and the 2020 EHSI Notes.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 20, 2015

 

ENDO INTERNATIONAL PLC
By:  

/s/ Matthew J. Maletta

Name:   Matthew J. Maletta
Title:   Executive Vice President,
  Chief Legal Officer


Index of Exhibits

 

Exhibit

Number

  

Description

99.1    Press Release of Endo International plc, dated November 20, 2015, related to the conditional redemption of the 2020 Endo Finance Notes and the 2020 EHSI Notes.